VI
STJ

Versor Investments’s St Jude Medical STJ Stock Holding History

Versor Investments’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-178,607
Closed -$14.3M – 156
2016
Q4 		$14.3M Buy
+178,607
New +$14.2M 5.79% 2

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Versor Investments's STJ Position: Q1 2017 in Review

Versor Investments sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 178,607 shares — an estimated $14.3M sold.

Versor Investments first reported a position in STJ in Q4 2016 and held it in 1 quarter. The position peaked at $14.3M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Versor Investments reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Versor Investments sold 178,607 St Jude Medical shares in Q1 2017, an estimated $14.3M.
  • Versor Investments first reported a position in St Jude Medical in Q4 2016 and held it in 1 quarter.
  • Versor Investments's St Jude Medical position peaked at $14.3M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Versor Investments's 13F filing for Q1 2017, filed 26 Apr 2017.